Clinical Trial Update: Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination [NA]

View source ↗

Summary

Clinical trial evaluating a probiotic and riboflavin combination to enhance neurocognition in individuals with mild cognitive impairment. The study status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Probiotic formulation
• Riboflavin (riboflavin)

Snippet

Sponsor: Center for Health Sciences, Serbia | Conditions: Cognitive Deficits, Mild | NA | Status: NOT_YET_RECRUITING